DexComvsEli Lilly and Company

DXCM and LLY stock compared: price, dividend, valuation and results, from SEC filings.

DXCM

DexCom, Inc.

$82.52

Value $31.8B

+0.53%
DXCM's page

LLY

Eli Lilly and Company

$1,382.75

Value $1.30T

-1.13%
LLY's page

DexCom (DXCM) has a market value of $31.8B and Eli Lilly and Company (LLY) $1.30T. Over the last year, with dividends, DXCM moved +41.3% and LLY +38.9%. The P/E is 32.1 for DXCM and 47.3 for LLY. Dividend yield: DXCM none, LLY 0.46%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    DXCM$31.8B

    LLY$1.30T

    LLY is 41 times DXCM

  • Revenue, 12 months

    DXCM$5.1B

    LLY$86.5B

    LLY is 17 times DXCM

  • Net income, 12 months

    DXCM$991M

    LLY$27.6B

    LLY is 28 times DXCM

  • Operating margin

    DXCM24.0%

    LLY–

  • ROIC

    DXCM19.5%

    LLY35.5%

    16.0 points apart

  • P/E

    DXCM32.1

    LLY47.3

    LLY is 1.5 times DXCM

  • Dividend yield

    DXCM0.0%

    LLY0.5%

    0.5 points apart

  • 5-year return

    DXCM-49.4%

    LLY+473.5%

    522.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

DXCM-49.4%

LLY+473.5%

20040060020222023202420252026
Returns by period
PeriodDXCMWith dividendsLLYWith dividends
1 year since November 14, 2025+41.3%Price +41.3%+38.9%Price +38.1%
3 years since November 17, 2023-21.8%-7.9% a yearPrice -21.8%+144.0%+34.6% a yearPrice +139.2%
5 years since November 16, 2021-49.4%-12.7% a yearPrice -49.4%+473.5%+41.8% a yearPrice +449.3%
10 years since November 18, 2016+359.6%+16.5% a yearPrice +359.6%+2,047.6%+35.9% a yearPrice +1,746.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

DXCMDexComLLYEli Lilly and Company

Valuation

DXCMLLY
Valuation
Price$82.52$1,382.75
Market value$31.8B$1.30T
Enterprise value (EV)$31.4B$1.35T
P/E32.147.3
P/E, 5-year median54.849.9
P/B12.532.4
EV/EBIT25.638.8
Free cash flow yield3.5%1.5%

Results and growth

DXCMLLY
Results and growth
Revenue, 12 months$5.1B$86.5B
Net income, 12 months$991M$27.6B
Free cash flow, 12 months$1.1B$19.7B
Earnings per share, 12 months$2.54$30.81
Revenue growth, year on year15.6%44.7%
Revenue growth a year, past+19.3%over 5 years+21.6%over 5 years
EPS growth a year, past+44.4%over 5 years+27.6%over 5 years

Margins and returns on capital

DXCMLLY
Margins and returns on capital
Gross margin63.4%83.6%
Operating margin24.0%–
Net margin19.4%31.9%
ROIC19.5%35.5%
ROE36.5%88.6%

Balance sheet

DXCMLLY
Balance sheet
Cash$1.7B$4.9B
Total debt$1.4B$49.5B
Net debt / EBITDA-0.31.2
Interest cover128.8×38.9×

Dividends and buybacks

DXCMLLY
Dividends and buybacks
Dividend yield–0.5%
Dividend per share, 12 months–$6.34
Dividend growth a year, past–+15.2%over 5 years
Buyback yield1.6%0.3%
Shareholder yield1.6%0.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: DXCM or LLY

Didn't find what you were looking for?

Ask us
Which is bigger, DexCom or Eli Lilly and Company?

By market value, Eli Lilly and Company ($1.30T) is about 41.1 times DexCom ($31.8B), at today's prices.

How did DXCM and LLY stock do over the last 10 years?

Since November 18, 2016, DXCM's price moved +359.6% and LLY's +1,746.3%. With dividends: DXCM +359.6% (+16.5% a year), LLY +2,047.6% (+35.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, DXCM or LLY?

The dividend yield at today's price is none for DexCom and 0.46% for Eli Lilly and Company. Over the last twelve months they paid – and $6.34 per share.

What is the P/E of DXCM and LLY?

At today's price, the P/E is 32.1 for DXCM and 47.3 for LLY. The median of the last five years was 54.8 and 49.9, which shows where each stands against its own past.

Which has the higher profit margins, DexCom or Eli Lilly and Company?

Over the last twelve months, the net margin was 19.4% for DexCom and 31.9% for Eli Lilly and Company, and the operating margin 24.0% and –. Revenue was $5.1B and $86.5B.

Which is the better investment, DexCom or Eli Lilly and Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.